Clinical Trials
2 trialsNCT03267498 2026-01-12
Nivolumab + Chemoradiation in Stage II-IVB Nasopharyngeal Carcinoma (NPC)
University of California, San Francisco
Phase 2 Completed
NCT02339558 2019-09-13
Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer
National Cancer Institute (NCI)
Phase 2 Completed